CoChat

Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical Trials

Vrijens, B, Urquhart, J · 2014 · Clinical Pharmacology & Therapeutics
Cited by 139

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Adherence to rationally prescribed medications is essential for effective pharmacotherapy. However, widely variable adherence to protocol-specified dosing regimens is prevalent among participants in ambulatory drug trials, mostly manifested in the form of underdosing. Drug actions are inherently dose and time dependent, and as a result, variable underdosing diminishes the actions of trial medications by various degrees. The ensuing combination of increased variability and decreased magnitude of trial drug actions reduces statistical power to discern between-group differences in drug actions. Variable underdosing has many adverse consequences, some of which can be mitigated by the combination of reliable measurements of ambulatory patients' adherence to trial and nontrial medications, measurement-guided management of adherence, statistically and pharmacometrically sound analyses, and modifications in trial design. Although nonadherence is prevalent across all therapeutic areas in which the patients are responsible for treatment administration, the significance of the adverse consequences depends on the characteristics of both the disease and the medications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/clpt.2014.59

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 53

  1. Harter J.G., 1991, Ann. N. Y. Acad. Sci, 618, 563, 10.1111/j.1749-6632.1991.tb27276.x · doi:10.1111/j.1749-6632.1991.tb27276.x
  2. Blaschke T.F., 2012, Annu. Rev. Pharmacol. Toxicol, 52, 275, 10.1146/annurev-pharmtox-011711-113247 · DOI · Paper page
  3. Czobor P., 2011, Mol. Interv, 11, 107, 10.1124/mi.11.2.8 · DOI · Paper page
  4. Vrijens B., 2008, BMJ, 336, 1114, 10.1136/bmj.39553.670231.25 · DOI · Paper page
  5. Sheiner L.B., 1995, Clin. Pharmacol. Ther, 57, 6, 10.1016/0009-9236(95)90260-0 · DOI · Paper page
  6. Cross J., 2002, Pharmacoepidemiol. Drug Saf, 11, 439, 10.1002/pds.744 · DOI
  7. Heerdink E.R., 2002, Pharmacoepidemiol. Drug Saf, 11, 447, 10.1002/pds.745 · DOI
  8. Kaitin K.I., 2010, Pharm. Outsourcing, 11, 28, 30,
  9. Kaitin K.I., 2011, Clin. Pharmacol. Ther, 89, 183, 10.1038/clpt.2010.286 · DOI · Paper page
  10. Kaitin K.I., 2008, Clin. Pharmacol. Ther, 83, 210, 10.1038/sj.clpt.6100462 · DOI
  11. Kaitin K.I., 2010, Clin. Pharmacol. Ther, 87, 356, 10.1038/clpt.2009.293 · DOI · Paper page
  12. Munos B., 2009, Nat. Rev. Drug Discov, 8, 959, 10.1038/nrd2961 · DOI · Paper page
  13. DiMasi J.A., 2010, Clin. Pharmacol. Ther, 87, 272, 10.1038/clpt.2009.295 · DOI · Paper page
  14. Djulbegovic B., 2014, JAMA, 311, 355, 10.1001/jama.2013.283742 · DOI
  15. Sacks L.V., 2014, JAMA, 311, 378, 10.1001/jama.2013.282542 · DOI · Paper page
  16. 2011, Morb. Mortal. Wkly. Rep, 60, 1153
  17. Pullar T., 1989, Clin. Pharmacol. Ther, 46, 163, 10.1038/clpt.1989.121 · DOI · Paper page
  18. Rudd P., 1989, Clin. Pharmacol. Ther, 46, 169, 10.1038/clpt.1989.122 · DOI · Paper page
  19. Matsui D., 1994, J. Clin. Pharmacol, 34, 944, 10.1002/j.1552-4604.1994.tb04009.x · DOI · Paper page
  20. Arnsten J.H., 2001, Clin. Infect. Dis, 33, 1417, 10.1086/323201 · DOI · Paper page
  21. Carroll C.L., 2004, J. Am. Acad. Dermatol, 51, 212, 10.1016/j.jaad.2004.01.052 · DOI · Paper page
  22. Vrijens B., 2005, Basic Clin. Pharmacol. Toxicol, 96, 225, 10.1111/j.1742-7843.2005.pto960312.x · doi:10.1111/j.1742-7843.2005.pto960312.x
  23. Halpern M.T., 2006, Hypertension, 47, 1039, 10.1161/01.HYP.0000222373.59104.3d · DOI · Paper page
  24. Vrijens B., 2005, J. Clin. Pharmacol, 45, 461, 10.1177/0091270004274433 · DOI · Paper page
  25. Liu H., 2001, Ann. Intern. Med, 134, 968, 10.7326/0003-4819-134-10-200105150-00011 · DOI · Paper page
  26. Averbuch M., 1990, J. Clin. Res. Pharmacoepidemiol, 4, 199
  27. Rubio A., 1992, Clin. Pharmacokinet, 22, 238, 10.2165/00003088-199222030-00006 · DOI
  28. Girard P., 1996, J. Pharmacokinet. Biopharm, 24, 265, 10.1007/BF02353671 · DOI
  29. Vrijens B., 1999, Stat. Methods Med. Res, 8, 247, 10.1191/096228099669221405 · DOI
  30. Savic R.M., 2012, Clin. Pharmacol. Ther, 92, 575, 10.1038/clpt.2012.137 · DOI
  31. Burnier M., 2001, J. Hypertens, 19, 335, 10.1097/00004872-200102000-00022 · DOI · Paper page
  32. Marin D., 2010, J. Clin. Oncol, 28, 2381, 10.1200/JCO.2009.26.3087 · DOI · Paper page
  33. Rosen M.I., 2004, Behav. Res. Ther, 42, 409, 10.1016/S0005-7967(03)00149-9 · DOI
  34. Cramer J.A., 1999, J. Nerv. Ment. Dis, 187, 53, 10.1097/00005053-199901000-00009 · DOI · Paper page
  35. Demonceau J., 2013, Drugs, 73, 545, 10.1007/s40265-013-0041-3 · DOI · Paper page
  36. Sommer A., 1991, Stat. Med, 10, 45, 10.1002/sim.4780100110 · DOI · Paper page
  37. Efron B., 1991, J. Amer. Statist. Assoc, 86, 9, 10.1080/01621459.1991.10474996 · DOI · Paper page
  38. Kruse W., 1990, Eur. J. Clin. Pharmacol, 38, 561, 10.1007/BF00278582 · DOI
  39. Urquhart J., 1994, Clin. Pharmacokinet, 27, 202, 10.2165/00003088-199427030-00004 · DOI · Paper page
  40. Urquhart J., 1998, Adv. Drug Deliv. Rev, 33, 207, 10.1016/S0169-409X(98)00029-5 · DOI
  41. Paterson D.L., 2000, Ann. Intern. Med, 133, 21, 10.7326/0003-4819-133-1-200007040-00004 · DOI · Paper page
  42. Bangsberg D.R., 2001, AIDS, 15, 1181, 10.1097/00002030-200106150-00015 · DOI · Paper page
  43. Lowy A., 2011, Int. J. Clin. Pract, 65, 41, 10.1111/j.1742-1241.2010.02569.x · DOI · Paper page
  44. Vrijens B., 2004, Stat. Med, 23, 531, 10.1002/sim.1619 · DOI
  45. Comté L., 2009, Clin. Trials, 6, 403, 10.1177/1740774509344777 · DOI
  46. Fischer K., 2011, Biostatistics, 12, 247, 10.1093/biostatistics/kxq053 · DOI
  47. Vrijens B., 2005, Stat. Med, 24, 2719, 10.1002/sim.2130 · DOI
  48. Osterberg L.G., 2010, Clin. Pharmacol. Ther, 88, 457, 10.1038/clpt.2010.171 · DOI · Paper page
  49. Comté L, 2007, J Pharmacokinet Pharmacodyn, 34, 549, 10.1007/s10928-007-9058-0 · DOI
  50. Van Damme L., 2012, N. Engl. J. Med, 367, 411, 10.1056/NEJMoa1202614 · DOI · Paper page
  51. Baeten J., 2012, Curr. Opin. HIV AIDS, 7, 514, 10.1097/COH.0b013e3283582d30 · DOI
  52. Haberer J.E., 2013, PLoS Med, 10, e1001511, 10.1371/journal.pmed.1001511 · DOI · Paper page
  53. Karim S.S., 2011, Lancet, 378, e23, 10.1016/S0140-6736(11)61136-7 · DOI

Cited by

See all 139

Metadata

Authors
Vrijens, B., & Urquhart, J.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2014-03-12
Volume
95
Issue
6
Pages
617-626
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2132001513
Cited by
139
References
13
FWCI
12.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical Trials. https://app.cochat.ai/papers/10.1038/clpt.2014.59
The paper
Vrijens, B., & Urquhart, J. (2014). Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical Trials. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.2014.59

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.